期刊文献+

阿尔茨海默病患者血清中巨噬细胞集落刺激因子 被引量:2

Serum Levels of Macrophage Colony Stimulating Factor in the Patients with Alzheimer's Disease
下载PDF
导出
摘要 目的寻找阿尔茨海默病(Alzheimersdisease,AD)患者早期诊断和监视病情动态变化的血清检测指标。方法检测70例AD患者、52例年龄匹配的健康人(对照组)和22例血管性痴呆(VAD)对照患者血清中巨噬细胞集落刺激因子(M-CSF)的水平,以及32例AD患者和20例年龄匹配的健康人(对照组)血清中IL-1β、IL-6、肿瘤坏死因子-α(TNF-α)水平,并结合AD患者的病情进行分析对比。结果AD患者组血清中M-CSF水平显著高于对照组(P<0.01)和VAD患者组(P<0.05);血清M-CSF水平主要在AD早期(轻、中度痴呆阶段)升高,在AD晚期(重度痴呆)则处于正常水平。AD患者组血清中IL-1β水平明显高于对照组(P<0.05),但血清中TNF-α和IL-6处于正常水平。结论血清M-CSF水平的检测是一种方便、敏感的方法,可望作为AD患者早期诊断的生物学标志。 Objective To in vestigate the availab ility of serum level of macrophage clony stimulating factor(M-CSF)a s a marker for early diagnosis of Alzheimer' s disease(AD).Methods The serum levels of M-CSF in70patients with AD,52healthy controls,22patients with VAD(vascular dementia)were measured and the serum levels of IL-1β,IL-6,TNF-αin32patients with AD and20controls were measured as well.Results Serum levels of M-CSF were significantly elevated in patients with AD when compared with healthy controls(P<0.01)and VAD controls(P<0.05)respectively.At the early stage of mild dementia and middle dementia,serum levels of M-CSF were significantly elevated,but at the later stage of severe dementia,they returned to normal level.Serum levels of IL-1βwere significantly elevated in AD patients compared with controls(P<0.05),and serum levels of TNF-αand IL-6were within the normal range in patients with AD.Conclusions The results suggest that serum M-CSF level may provide a convenient and sensitive means for the early diagnosis of Alzh-eimer's disease.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2002年第3期298-301,共4页 Acta Academiae Medicinae Sinicae
基金 中华医学基金会基金(99-699)资助
关键词 阿尔茨海默病 巨噬细胞集落刺激因子 早期诊断 AD Alzheimer's disease macrophage colony stimulating factor early diagnosis
  • 相关文献

参考文献11

  • 1[1]Ensoli F, Fiorelli V, Muratori DS, et al. Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators? Crit Rev Immuno,1999, 19:97-116
  • 2[2]Akiyama H, Nishimura T, Kondo H, et al. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Res, 1994, 639:171-174
  • 3[3]McGeer PL, Akiyama H, Itagaki S, et al. Immune systemresponse in Alzheimer's disease. J Neurol Sci, 1989, 16:516-527
  • 4[4]McGeer PI, Itagaki S, Tago H, et al. Reactive microglia in patients with senile dementia of Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett, 1987, 79:195-200
  • 5[5]Tarkowski E, Blennow K, Wallin A, et al. Intracerebral production tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer's disease and vascular dementia. JClin Immunol, 1999, 19:223-230
  • 6[6]Murphy GM, Zhao FF, Yang L, et al. Expression of mac rophage colony-stimulating factor receptor is increased inthe AβPPv717F transgenic mouse model of Alzheimer'sdisease. Am J Pathol, 2000, 157:895-904
  • 7[7]Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology, 1994, 44:227-232
  • 8[8]Bonaccorso S, Lin A, Song C, et al. serotonine-immune interactions in elderly volunteers and in patients with Alzheimer's disease(DAT): lower plasma tryptophan availab ility to the brain in elderly and increased serum interleukine-6 in DAT. Aging (Milano) , 1998, 10:316-323
  • 9[9]Yan SD, Zhu HJ, Fu J, et al. Amyloid-β peptide receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer's disease. Proc Natl Acad Sci USA, 1997, 94:5296-5301
  • 10[10]Hao C, Guilbert LJ, Fedoroff S. Production of the colony stimulating factor- 1 receptor ( CSF- 1 R) by mouse astroglia in vitro. J Neurosci Res, 1997, 27:314-323

同被引文献14

  • 1Cattabeni F, Colciaghi F, Di Luca M. Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease. Prog Neuropsychopharmacol Biol Psychiatry 2004;28(5):763-70.
  • 2Borroni B,Colciaghi F,Archetti S,et al.Predicting cognitive decline in Alzheimer disease.Role of platelet amyloid precursor protein.Alzheimer Dis Assoc Disord 2004;18(1):32-4.
  • 3Breitner JC,Gau BA,Welsh KA,et al.Inverse association of anti-inflammatory treatments and Alzheimer's disease:initial results of a co-twin control study.Neurology 1994;44(2):227-32.
  • 4Zandi PP,Anthony JC,Hayden KM,et al.Reduced incidence of AD with NSAID but not H2 receptor antagonists:the Cache County Study.Neurology 2002;59(6):880-6.
  • 5Cornelius C,Fastbom J,Winblad B,et al.Aspirin,NSAIDs,risk of dementia,and influence of the apolipoprotein E epsilon 4 allele in an elderly population.Neuroepide miology 2004;23(3):135-43.
  • 6Sala G. Periphral cytokine release in Alzheimer patients:correlation with disease severity[J]. Neurobiol Aging, 2003,24:909-914.
  • 7Federico L. Increased plasma levels of interleukin-1,interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? [J]. J Neuroimmunol,2000,103(1):97-102.
  • 8Bagli M, Papassotiropoulos A, Hampel H, et al. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease[J]. Eur Arch Psychiatry Clin Neurosci,2003, 253:44-48.
  • 9De Luigi A, Pizzimenti S, Quadri P, et al. Peripheral Inflammatory response in Alzheimer's disease and multiinfarct dementia [J].Neurobiol Dis ,2002,11:308-314.
  • 10Szczepanik AM. IL-4, IL-10 and IL-13 modulate Aβ1-42 induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line[J]. J Neuroimmunol, 2001,113(1):49-62.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部